Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: Possible relevance to HIF-1α

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 5, 2003, Pages 1096-1102

  Dupuy, E ^a   Habib, A ^b   Lebret, M ^b   Yang, R ^a   Levy Toledano, S ^b   Tobelem, G ^a  

^a Institut des Vaisseaux et du Sang   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Angiogenesis; HIF l ; Thrombin; VEGF

Indexed keywords

EID: 3042677724     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00208.x     Document Type: Article

References (39)

1. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
3. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Specific growth factors and blood vessel formation. Nature 2000; 407: 242-8.
4. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med 1999; 5: 1359-64.
5. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32: 2413-22.
6. Klagsbrun M, D'Amore PA. Vascular growth factor and its receptors. Cytokine Growth Factor Rev 1996; 7: 259-70.
7. Weltermann A, Wolzt M, Petersmann K, Czermi C, Graselli U, Lechner K, Kyrle PA. Large amounts of vascular endothelial cells at site of hemostatic plug formation in vivo. Arterioscler Thromb Vase Biol 1999; 19: 1757-60.
8. Celleti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 4: 403-4.
9. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions. Possible pathophysiological significance of VEGF in progression of athero sclerosis. Circulation 1998; 98: 2108-16.
10. Rosenthal RA, Megyesi JF, Henzel WJ, Ferrara N, Folkman J. Condi tioned medium from mouse sarcoma 180 cells contains vascular en dothelial growth factor. Growth Factors 1990; 4: 53-9.
11. Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 4: 207-18.
12. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 1995; 270: 31189-95.
13. Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996; 313: 353-68.
14. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407: 258-64.
15. Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997; 273: 239-45.
16. Huang Y-Q, Li J-J, Lu L, Lee M, Karpatkin S. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99: 1646-50.
17. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by regulation of its receptors. J Biol Chem 1999; 274: 23969-76.
18. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, Bahou WE Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 1995; 270: 23730-8.
19. Harker LA, Hanson SR, Runge MS. Thrombin hypothesis of thrombus generation and vascular formation. Am J Cardiol 1995; 75: 812-7.
20. Abendschein DR, Recchia D, Meng YY, Oltrona L, Wickline SA, Eisenberg PR. Inhibition of thrombin attenuates stenosis after arterial injury in minipigs. J Am Coll Cardiol 1996; 28: 1849-53.
21. Cheung W, D'Andrea MR, Andrade-Gordon P, Damiano BP. Altered vascular injury in mice deficient in protease-activated receptor-1. Arterioscler Thromb Vase Biol 1999; 19: 3014-24.
22. Smith EB, Crosbie L, Carey S. Prothrombin-related antigens in human aortic intima. Sem Thromb Hemost 1996; 22: 347-50.
23. Tenaglia AN, Petrs KG, Sketch MH, Annex BH. Neovascularization in atherectomy specimens from patients with unstable angina. Am Heart J 1998; 135: 10-4.
24. Zacharski LR, Mermoll VA, Morain WD, Schlaeppl JM, Rousseau SM. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 1995; 73: 793-7.
25. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovski S, Maoz M, Ginzburg Y, Vlodavsky I, Bar-Shavit R. Thrombin receptor overexpres-sion in malignant and physiological process. Nat Med 1998; 4: 909-14.
26. Ferrara N, Bunting S. Vascular endothelial cell growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 1996; 5: 35-44.
27. Bassus S, Herkert O, Kronemann N, Görlach A, Bremerich D, Kirch-maier CM, Busse R, Schini-Kerth VB. Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells. Role of reactive oxygen species. Arterioscler Thromb Vase Biol 2001; 21: 1550-5.
28. Huang Y-Q, Li J-J, Lu L, Lee M, Karpatkin S. Thrombin induces increased expression and secretion of VEGF from human FS4 fibro-blasts, DU 145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001; 86: 1094-8.
29. Forsythe JA, Jiang H-H, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-13.
30. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor lα in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765-71.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 1987; 162: 156-9.
32. Herbert JM, Dupuy E, Laplace MC, Zini JM, Bar Shavit R, Tobelem G. Thrombin induces endothelial cell growth via both proteolytic and non proteolytic pathway. Biochem J 1994; 303: 227-31.
33. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries; an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998; 141: 1659-73.
34. Parekh DB, Ziegler W, Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J 2000; 19: 496-503.
35. Richard D, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor lalpha (HIF-lalpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999; 274: 32631-7.
36. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, De-werchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshet E. Role of HIF-lα in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998; 394: 485-90.
37. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987-92.
38. phox-containing NADPH oxidase. Circ Res 2001; 89: 47-54.
39. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible HIF-lalpha/ARNT EMBO J 1998; 17: 5085-94.